Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
AltCap banks $55M in tax credits to bolster KC’s underserved entrepreneurs
A huge award will enable AltCap to make a broader entrepreneurial impact in low- to moderate-income communities throughout Kansas City. AltCap — a Kansas City-based community development financial institution that focuses on underserved populations — has received a $55 million new markets tax credit award from the U.S. Department of the Treasury. The award enables…
$17M Operation Breakthrough expansion to bridge Troost, boost STEM and maker skills
An Operation Breakthrough expansion from the east side of Troost Avenue to the west is about more than jumping across the street, said Mary Esselman. The move will literally bridge a racial and economic dividing line that has persisted for decades. “Bridging Troost is not only a legacy to our founders, but is huge symbolically,…
ClusterTruck sizzles on KC food delivery scene with ‘ghost kitchen’ concept
The innovation cooking within ClusterTruck’s technology makes the rapidly expanding Indianapolis company a fresh take on the restaurant-quality food delivery scene, Christian Moscoso said. “We are a software company with our own ghost kitchens, if you will,” said Moscoso, general manager for ClusterTruck’s new River Market kitchen, which opened in mid-December without a public entrance…
Innovation Exchange returns in 2018 with new partners, topics
One of my favorite parts of journalism is the “Hm!” moment. They are the occasions when reading, watching or listening to a story whose details yield an inborn reaction of fascination or intrigue. They can’t be stopped. When your curiosity piqued, “Hmm!” is an impulse. “The SpaceX Falcon Heavy rocket produced 5 million pounds of…